Preclinical studies of allograft tolerance in rhesus monkeys: A novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts

Transplantation

Volumn 64, Issue 1, 1997, Pages 124-135

  Thomas, Judith M ^a   Neville, David M ^b   Contreras, Juan L ^a   Eckhoff, Devin E ^a   Meng, Gang ^a   Lobashevsky, Andrew L ^a   Wang, Pei X ^a   Huang, Zhi Q ^a   Verbanac, Kathryn M ^c   Haisch, Carl E ^c   Thomas, Francis T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD3 ANTIGEN; IMMUNOTOXIN; MONOCLONAL ANTIBODY CD3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CADAVER KIDNEY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; ANTIGENS, CD3; B-LYMPHOCYTES; BONE MARROW; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; IMMUNE TOLERANCE; IMMUNOTOXINS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MACACA MULATTA; MALE; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030871990     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707150-00022     Document Type: Article

References (62)

1. Sykes M, Sachs DH. Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today 1988; 9: 23.
2. Sykes M. Chimerism and central tolerance. Curr Opin Immunol 1996; 8: 694.
3. Monaco AP, Wood ML, Maki T, et al. The use of donor-specific bone marrow to induce specific unresponsiveness (tolerance). In: Ildstad ST ed. Chimerism and tolerance. New York: Springer-Verlag, 1995: 99.
4. Naji A. Induction of tolerance by intrathymic inoculation of alloantigen. Curr Opin Immunol 1996; 8: 704.
5. Ildstad ST, Kaufman CL. Mixed allogeneic chimerism (A+B>A): donor-specific transplantation tolerance, superior immunocompetence, and a role for graft-facilitating cells. In: Ildstad ST, ed. Chimerism and tolerance. Austin, TX: RG Landes Company, 1995: 1.
6. Sprent J. The thymus and self tolerance. In: Ildstad ST, ed. Chimerism and tolerance. New York: Springer-Verlag, 1995: 1.
7. Wood KJ. Antigen induced tolerance. In Ildstad ST, ed. Chimerism and tolerance. New York: Springer-Verlag, 1995: 15.
8. Smith CV, Nakajima K, Mixon A, et al. Successful induction of long-term specific tolerance to fully allogeneic renal allografts in miniature swine. Transplantation 1992; 53: 438.
9. Gianello PR, Lorf T, Yamada K, et al. Induction of tolerance to renal allografts across single-haplotype MHC disparities in miniature swine. Transplantation 1995; 59: 884.
10. Rosengard BR, Ojikutu CA, Guzzetta PC, et al. Induction of specific tolerance to class I-disparate renal allografts in miniature swine with cyclosporine. Transplantation 1992; 54: 490.
11. Fishbein JM, Rosegard BR, Gianello P, et al. Development of tolerance to class H-mismatched renal transplants after a short course of cyclosporine therapy in miniature swine. Transplantation 1994; 57: 1303.
12. Thomas J, Carver M, Cunningham P, Park K, Gonder J. Promotion of incompatible allograft acceptance in rhesus monkeys given post-transplant antithymocyte globulin and donor bone marrow. I. In vivo parameters and immunohistologic evidence suggesting microchimerism. Transplantation 1987; 43: 332.
13. Thomas JM, Verbanac KM. Tolerance induction: basis, concepts and therapeutic approaches. In: Lieberman R, Mukherjee A, eds. Principles of drug development in transplantation and autoimmunity. Austin, TX: RG Landes Company, 1996: 59.
14. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256.
15. Moses RD, Orr KS, Bacher JD, Sachs DH, Clark RE, Gross RE. Cardiac allograft survival across major histocompatibility barriers in the rhesus monkey following T lymphocyte depleted autologous marrow transplantation. II. Prolonged allograft survival with extensive marrow T-cell depletion. Transplantation 1989; 47: 435.
16. Bieber CP, Jamieson S, Raney A, et al. Cardiac allograft survival in rhesus primates treated with combined total lymphoid irradiation and rabbit antithymocyte globulin. Transplantation 1979; 28: 347.
17. Pennock JL, Reitz BA, Bieber CP, et al. Survival of primates following orthotopic cardiac transplantation treated with total lymphoid irradiation and chemical immune suppression. Transplantation 1981; 32: 467.
18. Myburgh JA, Smit JA, Hill RRH, Browde S. Transplantation tolerance in primates following total lymphoid irradiation and allogeneic bone marrow injection. II. Renal allografts. Transplantation 1980; 29: 405.
19. Leonard A, Jonker M, Lagaaij E. Complete withdrawal of immunosuppression in allograft recipients. Transplantation 1996; 61: 1648.
20. Strober S, Modry DL, Hoppe RT, et al. Induction of specific unresponsiveness to heart allografts in mongrel dogs treated with total lymphoid irradiation and antithymocyte globulin. J Immunol 1984; 132: 1013.
21. Hartner WC, Markees TG, De Fazio SR, et al. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs. Transplantation 1991; 52: 784.
22. van Bekkum DW. The rhesus monkey as a preclinical model for bone marrow transplantation. Transplant Proc 1978; 10: 105.
23. Bontrop RE, Otting N, Slierendregt BL, Lanchbury JS. Evolution of major histocompatibility complex polymorphisms and T-cell receptor diversity in primates. Immunol Rev 1995; 143: 33.
24. Jaeger EE, Bontrop RE, Lanchbury JS. Structure, diversity, and evolution of the T cell receptor VB gene repertoire in primates. Immunogenetics 1994; 40: 184.
25. Burger H, Wagemaker G, Leunissen JAM, Dorssers LCJ. Molecular evolution and species specificity of interleukin-3. J Mol Evol 1994; 39: 255.
26. Van Beusechem VW, Valerio D. Gene transfer into hematopoietic stem cells of nonhuman primates. Hum Gene Ther 1996; 7: 1649.
27. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
28. Thomas J, Alqaisi M, Cunningham P, et al. The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression. Transplantation 1992; 53: 247.
29. Wood ML, Monaco AP, Gozzo JJ. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc 1971; 3: 676.
30. Hartner WC, DeFazio SR, Markees TG, Maki T, Monaco AP, Gozzo JJ. Specific tolerance to canine renal allografts following treatment with fractionated bone marrow and antilymphocyte serum. Transplant Proc 1987; 19: 476.
31. Wood ML, Monaco AP. Induction of unresponsiveness to skin allografts in adult mice disparate at defined regions of the H-2 complex. Transplantation 1984; 37: 35.
32. Thomas J, Kasten-Jolly J, Verbanac K, et al. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys. Transplantation 1995; 59: 245.
33. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996; 271: 1723.
34. Lenschow DJ, Bluestone JA. T cell co-stimulation and in vivo tolerance. Curr Opin Immunol 1993; 5: 747.
35. Rebellato L, Gross U, Carver M, et al. Treatment of rhesus monkey allograft recipients with a combination of anti-T-cell monoclonal antibodies. Transplant Proc 1993; 25: 598.
36. Hirsch R, Eckhaus M, Auchincloss HJ, Sachs DH, Bluestone JA. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses. J Immunol 1988; 140: 3766.
37. Mysliwietz J, Thierfelder S. Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell modulating and depleting antimouse CDS antibody is most effective when preinjected in the marrow recipient. Blood 1992; 80: 2661.
38. Neville DM Jr, Scharff J, Srinivasachar K. Anti-T cell immunotoxins: a look at post-endocytic receptor-mediated routing. J Controlled Release 1993; 24: 133.
39. Neville DM Jr, Scharff J, Hu HZ, Rigaut K. A new reagent for the induction of T cell depletion anti-CD3-CRM9. J Immunother 1996; 19: 85.
40. Knechtle SJ, Vargo D, Fechner J, et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 1997; 63: 1.
41. Neville DM Jr, Scharff J, Srinivasachar K. In vivo T-cell ablation hy a holo-immunotoxin directed at human CD3. Proc Natl Acad Sci USA 1992; 89: 2585.
42. Alqaisi M, Carver M, Cunningham P, Kasten-Jolly J, Thomas F, Thomas J. Effect of depleting CD3+ cells from DR- donor bone marrow to facilitate kidney graft tolerance in recipients given total lymphoid irradiation. Transplant Proc 1993; 25: 344.
43. Slierendregt BL, Bakas JT. Evolutionary stability of trans-species major histocompatibility complex class II DRB lineages in humans and rhesus monkeys. Hum Immunol 1992; 35: 29.
44. Slierendregt BL, van Besour N. Expansion and construction of rhesus macaque DRB regions by duplication and deletion. J Immunol 1994; 152: 2298.
45. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies: data analysis. J Immunol 1981; 126: 1614.
46. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991.
47. Guerder S, Matzinger P. A fail-safe mechanism for maintaining self-tolerance. J Exp Med 1992; 176: 553.
48. Thompson J, Hu H, Scharff J, Neville DM Jr. An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood. J Biol Chem 1995; 270: 28037.
49. Ma S, Thompson J, Hu H, Neville DM Jr. Expression and characterization of a divalent chimeric anti-human CD3 single chain antibody. Scand J Immunol 1996; 46: 134.
50. Barber WH, Mankin J, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
51. Rolles K, Burroughs AK, Davidson BR, Karatapanis S, Prentice HG, Hamon MD. Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet 1994; 343: 263.
52. Shapiro R, Rao AS, Fontes P, et al. Combined simultaneous kidney/bone marrow transplantation. Transplantation 1995; 60: 1421.
53. Ricordi C, Karratzas T, Selvaggi G, et al. Multiple bone marrow infusion to enhance acceptance of allografts from the same donor. Ann NY Acad Sci 1995; 770: 345.
54. Vitetta ES, Thorpe PE, Uhr JW. Immunotoxins: magic bullets or misguided missiles? Immunol Today 1993; 14: 252.
55. Grossbard ML, Nadler LM. Immunotoxin therapy of lymphoid neoplasms. Semin Hematol 1994; 31: 88.
56. Wazrzynzczak EJ, Derbyshire EJ. Immunotoxins: the poser and the glory. Immunol Today 1992; 13: 381.
57. Rebellato LM, Gross U, Verbanac KM, Thomas JM. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation 1994; 57: 685.
58. Alard P, Matriano JA, Socarras S, Ortega MA, Streilein JW. Detection of donor-derived cells by polymerase chain reaction in neonatally tolerant mice: microchimerism fails to predict tolerance. Transplantation 1995; 60: 1125.
59. Bushell A, Pearson TC, Morris PJ, Wood KJ. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti- CD4 antibody: evidence of a clear role for short-term antigen persistence. Transplantation 1995; 59: 1367.
60. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism and allograft survival. Immunol Today 1996; 17: 577.
61. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance (review). Stem Cells 1995; 13: 622.
62. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659.